Loading...
XNYS
COO
Market cap14bUSD
Jan 08, Last price  
91.88USD
Name

Cooper Companies Inc

Chart & Performance

D1W1MN
XNYS:COO chart
No data to show
P/E
46.73
P/S
4.71
EPS
1.97
Div Yield, %
Shrs. gr., 5y
0.04%
Rev. gr., 5y
7.98%
Revenues
3.90b
+8.41%
806,617,000858,960,000950,641,0001,063,176,0001,080,421,0001,158,517,0001,330,835,0001,445,136,0001,587,725,0001,717,776,0001,797,060,0001,966,814,0002,139,000,0002,532,800,0002,653,400,0002,430,900,0002,922,500,0003,308,400,0003,593,200,0003,895,400,000
Net income
392m
+33.34%
91,722,00066,234,000-11,192,00065,476,000100,548,000112,803,000175,430,000248,339,000296,151,000269,856,000203,523,000273,917,000372,900,000139,900,000466,700,000238,400,0002,944,700,000385,800,000294,200,000392,300,000
CFO
709m
+16.76%
183,843,000162,716,000133,984,00096,528,000223,128,000267,663,000336,281,000315,121,000415,925,000454,823,000390,970,000509,637,000593,600,000668,900,000713,200,000486,600,000738,600,000692,400,000607,500,000709,300,000
Dividend
Jul 26, 20230.03 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
IPO date
Jan 21, 1983
Employees
15,000
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑102023‑102022‑102021‑102020‑102019‑102018‑102017‑102016‑102015‑10
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT